Cargando…

Interferon–β Induces Hepatocyte Growth Factor in Monocytes of Multiple Sclerosis Patients

Interferon-β is a first-line therapy used to prevent relapses in relapsing-remitting multiple sclerosis. The clinical benefit of interferon-β in relapsing-remitting multiple sclerosis is attributed to its immunomodulatory effects on inflammatory mediators and T cell reactivity. Here, we evaluated th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molnarfi, Nicolas, Benkhoucha, Mahdia, Bjarnadóttir, Kristbjörg, Juillard, Catherine, Lalive, Patrice H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498184/ https://www.ncbi.nlm.nih.gov/pubmed/23166786 http://dx.doi.org/10.1371/journal.pone.0049882

Ejemplares similares

Activation of human B cells negatively regulates TGF-β1 production
por: Molnarfi, Nicolas, et al.
Publicado: (2017)

B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation
por: Bjarnadóttir, Kristbjörg, et al.
Publicado: (2016)

The neurotrophic hepatocyte growth factor attenuates CD8(+) cytotoxic T-lymphocyte activity
por: Benkhoucha, Mahdia, et al.
Publicado: (2013)

IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis
por: Benkhoucha, Mahdia, et al.
Publicado: (2012)

c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
por: Benkhoucha, Mahdia, et al.
Publicado: (2020)

c-Met enforces proinflammatory and migratory features of human activated CD4(+) T cells
por: Benkhoucha, Mahdia, et al.
Publicado: (2021)

Glatiramer acetate treatment negatively regulates type I interferon signaling
por: Molnarfi, Nicolas, et al.
Publicado: (2015)

Nogo-A Downregulation Improves Insulin Secretion in Mice
por: Bonal, Claire B., et al.
Publicado: (2013)

MHC class II–restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell–mediated autoimmunity
por: Irla, Magali, et al.
Publicado: (2010)

CD4(+)c-Met(+)Itgα4(+) T cell subset promotes murine neuroinflammation
por: Benkhoucha, Mahdia, et al.
Publicado: (2022)

Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease
por: Weber, Martin S., et al.
Publicado: (2010)

Oral contraceptives combined with interferon β in multiple sclerosis
por: Pozzilli, Carlo, et al.
Publicado: (2015)

Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study
por: Bridel, Claire, et al.
Publicado: (2015)

Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta
por: Bustamante, Marta F., et al.
Publicado: (2013)

Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
por: Creeke, Paul I., et al.
Publicado: (2013)

Differential induction of IL-1β and tumor necrosis factor by CD40 ligand or cellular contact with stimulated T cells depends on the degree of maturity of human monocytes
por: Burger, D, et al.
Publicado: (2004)

Personality as a Predictor of Disability in Multiple Sclerosis
por: Jacot de Alcântara, Isabele, et al.
Publicado: (2023)

Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis
por: Menge, Til, et al.
Publicado: (2011)

Cerebrospinal Fluid Interleukin-6 in Central Nervous System Inflammatory Diseases
por: Wullschleger, Alexandre, et al.
Publicado: (2013)

Oral Cladribine Impairs Intermediate, but Not Conventional, Monocyte Transmigration in Multiple Sclerosis Patients across a Model Blood-Brain Barrier
por: Lin, Linda Y., et al.
Publicado: (2023)

Interferons and Natalizumab for Multiple Sclerosis
por: Clar, Christine, et al.
Publicado: (2008)

Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010)

Interferon Treatment of Multiple Sclerosis
por: Alajbegovic, Azra, et al.
Publicado: (2012)

Early stage and long term treatment of multiple sclerosis with interferon-β
por: Applebee, Angela, et al.
Publicado: (2009)

Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis
por: Kolb-Mäurer, Annette, et al.
Publicado: (2015)

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients
por: Lalive, Patrice H., et al.
Publicado: (2017)

Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients
por: Waschbisch, Anne, et al.
Publicado: (2014)

Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
por: Fernández, Oscar, et al.
Publicado: (2012)

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
por: Hegen, Harald, et al.
Publicado: (2016)

Different molecules at the surface of stimulated T cells induce IL-1beta, tumour necrosis factor and IL-1RA in human monocytes
por: Burger, D, et al.
Publicado: (2005)

Selective APRIL Blockade Delays Systemic Lupus Erythematosus in Mouse
por: Huard, Bertrand, et al.
Publicado: (2012)

Review of the clinical evidence for interferon β 1a (Rebif(®)) in the treatment of multiple sclerosis
por: Manfredonia, Francesco, et al.
Publicado: (2008)

Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases
por: Etemadifar, Masoud, et al.
Publicado: (2011)

Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
por: Fernández, Oscar, et al.
Publicado: (2012)

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis
por: Zhornitsky, Simon, et al.
Publicado: (2015)

Bone marrow sarcoidosis associated with long‐term interferon‐β treatment for multiple sclerosis
por: Teh, Angela, et al.
Publicado: (2016)

Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
por: Dunn, Nicky, et al.
Publicado: (2020)

Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
por: Simpson-Yap, Steve, et al.
Publicado: (2022)

Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
por: Börnsen, Lars, et al.
Publicado: (2015)

Different molecules at the surface of stimulated T cells induce IL-1α, tumor necrosis factor and IL-1 receptor antagonist in human monocytes
por: Burger, D, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_5pg954d7eam0c9bv1c789f498a